What is the current Chromadex market capitalization?
The current market capitalization of Chromadex is 276.69 M USD.
Chromadex Market capitalization 2024
Chromadex Market capitalization
276.69 M USD
Chromadex Dividend yield
Ticker
CDXC
ISIN
US1710774076
WKN
A2AG5N
In 2024, Chromadex's market cap stood at 276.69 M USD, a 171.72% increase from the 101.83 M USD market cap in the previous year.
The Chromadex Market capitalization history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) | NET INCOME (undefined USD) |
|---|---|---|---|
| 2026e | 140.66 | 36,10 | 8.45 |
| 2025e | 116.66 | 43,53 | 4.1 |
| 2024e | 99.53 | 51,02 | -1.02 |
| 2023 | 83.57 | 60,76 | -4.94 |
| 2022 | 72.05 | 59,40 | -16.54 |
| 2021 | 67.45 | 61,51 | -27.13 |
| 2020 | 59.26 | 59,52 | -19.93 |
| 2019 | 46.29 | 55,67 | -32.15 |
| 2018 | 31.56 | 50,89 | -33.32 |
| 2017 | 21.2 | 49,43 | -11.38 |
| 2016 | 21.66 | 47,97 | -2.93 |
| 2015 | 22.01 | 38,53 | -2.77 |
| 2014 | 15.31 | 34,81 | -5.39 |
| 2013 | 10.16 | 30,81 | -4.42 |
| 2012 | 11.61 | 19,64 | -11.66 |
| 2011 | 8.11 | 30,46 | -7.89 |
| 2010 | 7.57 | 38,84 | -2.05 |
| 2009 | 5.78 | 35,29 | -0.91 |
| 2008 | 4.51 | 27,27 | -2.1 |
| 2007 | 4.75 | 34,32 | -0.19 |
| 2006 | - | - | - |
Chromadex Aktienanalyse
What does Chromadex do?
The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Chromadex ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Chromadex's Market Capitalization
Chromadex's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Chromadex's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Chromadex's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Chromadex’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Chromadex Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Chromadex.
How has the market capitalization of Chromadex developed in recent years?
The market capitalization of Chromadex has increased/decreased by 171.72% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Chromadex?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Chromadex?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Chromadex have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Chromadex pay?
Over the past 12 months, Chromadex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chromadex is expected to pay a dividend of 0 USD.
What is the dividend yield of Chromadex?
The current dividend yield of Chromadex is .
When does Chromadex pay dividends?
Chromadex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Chromadex?
Chromadex paid dividends every year for the past 0 years.
What is the dividend of Chromadex?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Chromadex located?
Chromadex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Chromadex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Chromadex from 4/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/20/2024.
When did Chromadex pay the last dividend?
The last dividend was paid out on 4/20/2024.
What was the dividend of Chromadex in the year 2023?
In the year 2023, Chromadex distributed 0 USD as dividends.
In which currency does Chromadex pay out the dividend?
The dividends of Chromadex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Chromadex stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Chromadex
Our stock analysis for Chromadex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chromadex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
